IASO206 in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07322159 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07322159
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-15
- Primary completion
- 2026-10-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.